{"title":"Fragrance Allergy Statistics 2026: Europe and New EU Labels","source":"https://www.scento.com/blog/fragrance-allergy-statistics-2026","creator":"Scento","license":"https://creativecommons.org/licenses/by/4.0/","citation":"Scento (2026). Fragrance Allergy Statistics 2026: Europe and New EU Labels. https://www.scento.com/blog/fragrance-allergy-statistics-2026","dateModified":"2026-10-26T07:00:00.000Z","tables":[{"index":1,"name":"Fragrance contact allergy in Europe by study","columns":["Study (name, year)","Population","Countries","Study size (people)","Allergen or measure","Positive","Source"],"rows":[{"Study (name, year)":"EDEN, 2015","Population":"General population","Countries":"Germany, Italy, the Netherlands, Portugal, Sweden","Study size (people)":"3,119","Allergen or measure":"Any fragrance, clinically relevant","Positive":"1.9%","Source":"2"},{"Study (name, year)":"EDEN, 2015","Population":"General population","Countries":"Five countries","Study size (people)":"3,119","Allergen or measure":"Fragrance mix I","Positive":"2.6%","Source":"2"},{"Study (name, year)":"EDEN, 2015","Population":"General population","Countries":"Five countries","Study size (people)":"3,119","Allergen or measure":"Fragrance mix II","Positive":"1.9%","Source":"2"},{"Study (name, year)":"Alinaghi meta-analysis, 2019","Population":"General population","Countries":"Pooled, 28 studies","Study size (people)":"20,107","Allergen or measure":"Fragrance mix I","Positive":"3.5%","Source":"8"},{"Study (name, year)":"ESSCA, 2019/20","Population":"Clinic patients","Countries":"13 European countries","Study size (people)":"22,581","Allergen or measure":"Fragrance mix I","Positive":"6.80%","Source":"7"},{"Study (name, year)":"ESSCA, 2019/20","Population":"Clinic patients","Countries":"13 European countries","Study size (people)":"22,581","Allergen or measure":"Myroxylon pereirae","Positive":"6.62%","Source":"7"},{"Study (name, year)":"ESSCA, 2019/20","Population":"Clinic patients","Countries":"13 European countries","Study size (people)":"22,581","Allergen or measure":"Fragrance mix II","Positive":"3.77%","Source":"7"},{"Study (name, year)":"ESSCA, 2019/20","Population":"Clinic patients","Countries":"13 European countries","Study size (people)":"22,581","Allergen or measure":"HICC","Positive":"1.32%","Source":"7"},{"Study (name, year)":"ESSCA, 2019/20","Population":"Clinic patients","Countries":"13 European countries","Study size (people)":"22,581","Allergen or measure":"Any of FM I, FM II, HICC, Myroxylon pereirae","Positive":"10.3%","Source":"7"},{"Study (name, year)":"IVDK, 2018–2020","Population":"Clinic patients","Countries":"Germany","Study size (people)":"5,511","Allergen or measure":"Linalool hydroperoxides 1%","Positive":"8.8%","Source":"10"},{"Study (name, year)":"IVDK, 2018–2020","Population":"Clinic patients","Countries":"Germany","Study size (people)":"5,511","Allergen or measure":"Limonene hydroperoxides 0.3%","Positive":"3.1%","Source":"10"},{"Study (name, year)":"REIDAC, 2019–2024","Population":"Clinic patients","Countries":"Spain","Study size (people)":"10,502","Allergen or measure":"Linalool hydroperoxides 1%","Positive":"5.3%","Source":"11"},{"Study (name, year)":"REIDAC, 2019–2024","Population":"Clinic patients","Countries":"Spain","Study size (people)":"10,502","Allergen or measure":"Limonene hydroperoxides 0.3%","Positive":"4.1%","Source":"11"},{"Study (name, year)":"UK audit, 2013–2014","Population":"Clinic patients","Countries":"United Kingdom","Study size (people)":"4,563","Allergen or measure":"Linalool hydroperoxide 1.0%","Positive":"7.7%","Source":"12"},{"Study (name, year)":"UK audit, 2013–2014","Population":"Clinic patients","Countries":"United Kingdom","Study size (people)":"4,563","Allergen or measure":"Limonene hydroperoxide 0.3%","Positive":"5.3%","Source":"12"},{"Study (name, year)":"Malmö, 2013–2020","Population":"Clinic patients","Countries":"Sweden","Study size (people)":"5,773","Allergen or measure":"Oxidised linalool","Positive":"7.0%","Source":"13"},{"Study (name, year)":"Malmö, 2013–2020","Population":"Clinic patients","Countries":"Sweden","Study size (people)":"5,773","Allergen or measure":"Oxidised limonene","Positive":"5.1%","Source":"13"}]}]}